QUEST DIAGNOSTICS INCORPORATED PERFORMANCE SHARE AWARD AGREEMENT (CEO) (2007 – 2009 Performance Period)Performance Share Award Agreement • February 22nd, 2008 • Quest Diagnostics Inc • Services-medical laboratories • New York
JOINDER AGREEMENTJoinder Agreement • February 22nd, 2008 • Quest Diagnostics Inc • Services-medical laboratories
THIS JOINDER AGREEMENT is executed and delivered by LabOne, Inc., a Missouri corporation; Central Plains Laboratories, LLC, a Kansas limited liability company; LabOne of Ohio, Inc., a Delaware corporation; ExamOne World Wide, Inc., a Pennsylvania corporation; and Systematic Business Services, Inc., a Missouri corporation (collectively, “New Sellers”) in favor of Quest Diagnostics Receivables Inc., a Delaware corporation, as purchaser (the “Buyer”), with respect to that certain Second Amended and Restated Receivables Sale Agreement dated as of April 20, 2004, by and between Quest Diagnostics Incorporated and certain of its wholly-owned subsidiaries from time to time party thereto as “Sellers” and the Buyer (as amended, supplemented, joined, restated and/or otherwise modified from time to time, the “Sale Agreement”). Capitalized terms used and not otherwise defined herein are used with the meanings attributed thereto in the Sale Agreement.
QUEST DIAGNOSTICS INCORPORATED NON-QUALIFIED STOCK OPTION AGREEMENT (CEO)Non-Qualified Stock Option Agreement • February 22nd, 2008 • Quest Diagnostics Inc • Services-medical laboratories • New York
This Non-Qualified Stock Option Agreement (the “Option Agreement”), dated as of February 12, 2007 (the “Grant Date”), is by and between Quest Diagnostics Incorporated, 1290 Wall Street West, Lyndhurst, New Jersey 07071 (the “Corporation” or the “Company”) and Surya Mohapatra (the “Optionee”) 85 Fox Hedge Road, Saddle River, NJ 07458.
CONFIDENTIAL Letter of Agreement between SmithKline Beecham Corporation And Quest Diagnostics IncorporatedGlobal Clinical Trials Agreement • February 22nd, 2008 • Quest Diagnostics Inc • Services-medical laboratories
This Letter of Agreement (“LOA”), effective as of January 1, 2008, is made between SmithKline Beecham Corporation d/b/a GlaxoSmithKline with a primary address at 2301 Renaissance Blvd, King of Prussia, PA 19406 USA, together with its affiliates (“GlaxoSmithKline” or “GSK”) and Quest Diagnostics Incorporated, with a primary address at 3 Giralda Farms, Madison, NJ 07940 together with its affiliates (“Quest Diagnostics”) together “the Parties”, to revise the relationship previously established in the Amended and Restated Global Clinical Trials Agreement dated December 19, 2002 (hereinafter “Previous Agreement”). “Affiliates” for purposes of this LOA shall include any corporation or non-corporate entity which controls, is controlled by, or is under common control with a Party to this LOA.
